ABT vs. SOLV: Abbott Laboratories vs. Solventum Stock Comparison

November 11, 2026

How do Abbott Laboratories (ABT) and Solventum (SOLV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Abbott Laboratories (ABT) and Solventum (SOLV) both belong to the Health Care Equipment & Supplies industry, though ABT is classified under Health Care Equipment while SOLV falls under Health Care Supplies.

Abbott Laboratories (ABT) carries decades of public-market history since March 17, 1980, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the ABT side.

Company profile comparison for Abbott Laboratories (ABT) and Solventum (SOLV)
Profile Item	ABT	SOLV
Name	Abbott Laboratories	Solventum Corporation
Country/Region	United States	United States
GICS Sector	Health Care	Health Care
GICS Industry Group	Health Care Equipment & Services	Health Care Equipment & Services
GICS Industry	Health Care Equipment & Supplies	Health Care Equipment & Supplies
GICS Sub-Industry	Health Care Equipment	Health Care Supplies
Market Capitalization	190.39 billion USD	15.36 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	March 17, 1980	March 26, 2024
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

ABT

SOLV

GSPC

Abbott Laboratories (ABT) vs. Solventum (SOLV), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Abbott Laboratories (ABT) and Solventum (SOLV). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Abbott Laboratories (ABT) and Solventum (SOLV). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Abbott Laboratories (ABT) and Solventum (SOLV)
Metric	ABT	SOLV
Total Return (1Y)	-10.78%	25.89%
Total Return (3Y, Annualized)	7.79%	--
Total Return (5Y, Annualized)	-0.79%	--

Risk Profile

Drawdown History

ABT

SOLV

GSPC

Abbott Laboratories (ABT) vs. Solventum (SOLV), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Abbott Laboratories (ABT) and Solventum (SOLV). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Abbott Laboratories (ABT) and Solventum (SOLV)
Metric	ABT	SOLV
Volatility (1Y, Annualized)	28.48%	30.06%
Beta (5Y)	0.53	0.62
Max Drawdown (5Y)	-39.64%	-39.98%
Avg. Volume (3M)	8.74M	1.05M

Risk-Adjusted Performance

Risk-Return Positioning

ABT and SOLV are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Abbott Laboratories (ABT) and Solventum (SOLV)
Metric	ABT	SOLV
Sharpe Ratio (1Y)	-0.53	0.72
Sortino Ratio (1Y)	-0.76	1.08

Profitability

ROE (TTM)

Both Abbott Laboratories (ABT) at 9.14% and Solventum (SOLV) at 3.19% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

ABT

Health Care Equipment & Services industry group

9.14%

Max: 47.61%
Q3: 14.36%
ABT: 9.14%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

SOLV

Health Care Equipment & Services industry group

3.19%

Max: 47.61%
Q3: 14.36%
Median: 5.45%
SOLV: 3.19%
Q1: -10.67%
Min: -47.01%

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

Abbott Laboratories (ABT) at 9.75% retains a top-quartile share of revenue as profit, ahead of Solventum (SOLV) at 1.91%, which keeps about the industry-typical share.

ABT

Health Care Equipment & Services industry group

9.75%

Max: 29.35%
ABT: 9.75%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

SOLV

Health Care Equipment & Services industry group

1.91%

Max: 29.35%
Q3: 9.33%
Median: 2.18%
SOLV: 1.91%
Q1: -6.29%
Min: -28.46%

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

Both Abbott Laboratories (ABT) at 11.66% and Solventum (SOLV) at 6.82% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

ABT

Health Care Equipment & Services industry group

11.66%

Max: 35.43%
Q3: 14.14%
ABT: 11.66%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

SOLV

Health Care Equipment & Services industry group

6.82%

Max: 35.43%
Q3: 14.14%
SOLV: 6.82%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for Abbott Laboratories (ABT) and Solventum (SOLV)
Metric	ABT	SOLV
ROE (TTM)	9.14%	3.19%
ROA (TTM)	4.90%	2.29%
Net Margin (TTM)	9.75%	1.91%
Operating Margin (TTM)	11.66%	6.82%
Gross Margin (TTM)	57.17%	55.13%

Growth

Revenue Growth

Abbott Laboratories (ABT) at 5.67% is around its peer norm for revenue growth, while Solventum (SOLV) at 0.86% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their Revenue Growth across different time periods.

EPS Growth

Solventum (SOLV) at 221.74% delivers above-range EPS growth, while Abbott Laboratories (ABT) at -51.31% falls into the bottom quartile — a wide split in earnings momentum.

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Abbott Laboratories (ABT) and Solventum (SOLV)
Metric	ABT	SOLV
Revenue Growth (YoY)	5.67%	0.86%
Revenue Growth (3Y CAGR)	0.51%	0.79%
EPS Growth (YoY)	-51.31%	221.74%
EPS Growth (3Y CAGR)	-1.65%	4.51%

Financial Strength

Current Ratio (MRQ)

Abbott Laboratories (ABT) at 1.46 keeps current ratio within its industry’s typical mid-range, while Solventum (SOLV) at 1.03 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for SOLV.

ABT

Health Care Equipment & Services industry group

1.46

Max: 7.59
Q3: 4.00
Median: 1.98
ABT: 1.46
Q1: 1.37
Min: 0.30

SOLV

Health Care Equipment & Services industry group

1.03

Max: 7.59
Q3: 4.00
Median: 1.98
Q1: 1.37
SOLV: 1.03
Min: 0.30

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

Abbott Laboratories (ABT) at 0.61 carries an industry-typical debt-to-equity mix, while Solventum (SOLV) at 1.10 uses more debt funding than most peers.

ABT

Health Care Equipment & Services industry group

0.61

Max: 1.88
Q3: 0.91
ABT: 0.61
Median: 0.58
Q1: 0.16
Min: 0.00

SOLV

Health Care Equipment & Services industry group

1.10

Max: 1.88
SOLV: 1.10
Q3: 0.91
Median: 0.58
Q1: 0.16
Min: 0.00

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Abbott Laboratories (ABT) and Solventum (SOLV)
Metric	ABT	SOLV
Current Ratio (MRQ)	1.46	1.03
Debt / Equity (MRQ)	0.61	1.10
Net Debt / EBITDA	2.37	4.66

Dividends

Dividend Yield (TTM)

Solventum (SOLV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a yield of 2.22%, ranking against industry peers normally.

ABT

Health Care Equipment & Services industry group

2.22%

ABT: 2.22%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

SOLV

Health Care Equipment & Services industry group

0.00%

SOLV: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

Solventum (SOLV) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a payout of 92.54%, ranking against industry peers normally.

ABT

Health Care Equipment & Services industry group

92.54%

ABT: 92.54%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

SOLV

Health Care Equipment & Services industry group

0.00%

SOLV: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for Abbott Laboratories (ABT) and Solventum (SOLV)
Metric	ABT	SOLV
Dividend Yield (TTM)	2.22%	0.00%
Dividend Payout Ratio (TTM)	92.54%	0.00%

Valuation

P/E Ratio (TTM)

Abbott Laboratories (ABT) at 41.02 is near its industry’s usual P/E ratio, while Solventum (SOLV) at 101.55 sits above its peer range — an unusually expensive price for SOLV’s trailing earnings.

ABT

Health Care Equipment & Services industry group

41.02

Max: 80.41
Q3: 47.62
ABT: 41.02
Median: 29.93
Q1: 21.19
Min: 4.21

SOLV

Health Care Equipment & Services industry group

101.55

SOLV: 101.55
Max: 80.41
Q3: 47.62
Median: 29.93
Q1: 21.19
Min: 4.21

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their P/E ratio against the Health Care Equipment & Services industry group benchmark.

P/S Ratio (TTM)

On P/S ratio, both Abbott Laboratories (ABT) at 3.95 and Solventum (SOLV) at 1.88 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

ABT

Health Care Equipment & Services industry group

3.95

Max: 8.80
Q3: 4.32
ABT: 3.95
Median: 2.13
Q1: 1.10
Min: 0.03

SOLV

Health Care Equipment & Services industry group

1.88

Max: 8.80
Q3: 4.32
Median: 2.13
SOLV: 1.88
Q1: 1.10
Min: 0.03

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

On P/B ratio, both Abbott Laboratories (ABT) at 3.73 and Solventum (SOLV) at 3.20 are valued close to their industries’ norm against book — neither stands out from peers.

ABT

Health Care Equipment & Services industry group

3.73

Max: 11.68
Q3: 6.12
ABT: 3.73
Median: 3.00
Q1: 1.73
Min: -1.31

SOLV

Health Care Equipment & Services industry group

3.20

Max: 11.68
Q3: 6.12
SOLV: 3.20
Median: 3.00
Q1: 1.73
Min: -1.31

Abbott Laboratories (ABT) vs. Solventum (SOLV): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for Abbott Laboratories (ABT) and Solventum (SOLV)
Metric	ABT	SOLV
P/E Ratio (TTM)	41.02	101.55
P/S Ratio (TTM)	3.95	1.88
P/B Ratio (MRQ)	3.73	3.20
Free Cash Flow Yield (TTM)	3.19%	1.31%